Hillstar Bio
PrivateLast Round
Series A
Mar 25, 2025
Total Funding Raised
$67M
Company Overview
Hillstar Bio is a biotechnology company that develops next-generation precision immunology therapies for autoimmune diseases by selectively targeting and depleting pathogenic immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hillstar Bio Comparables
Compare Hillstar Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 82% | |
| Seismic | 74% | |
| AbbVie | 68% | |
Hillstar Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 25, 2025 |
Hillstar Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Series A |
| Frazier Life Sciences | Series A |
| Novo Holdings | Series A |
| LifeArc Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2025
Grew 28% QoQ, from 18 to 23 employees.
- May 28, 2025
Maude Tessier appointed as new Chief Operating Officer.
Hillstar Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hillstar Bio's valuation, stock price, and market status.